Particularly relevant for future applications, this tumor/normal cell lines contains hallmark clinically relevant mutations spanning different mutation classes, including a BRAF V600E SNV, a PTEN 12 kb focal deletion, a TERT dinucleotide block substitution, and a 2 bp small deletion in CDK2NA. The gene discussed is BRAF; the disease is neoplasm.